Crossmark Global Holdings Inc. Has $12.24 Million Stock Position in Relx Plc (NYSE:RELX)

Crossmark Global Holdings Inc. boosted its position in Relx Plc (NYSE:RELX) by 2.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 269,580 shares of the technology company’s stock after acquiring an additional 5,471 shares during the period. Crossmark Global Holdings Inc.’s holdings in Relx were worth $12,244,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. JPMorgan Chase & Co. boosted its position in shares of Relx by 14.6% during the third quarter. JPMorgan Chase & Co. now owns 826,481 shares of the technology company’s stock worth $39,225,000 after purchasing an additional 104,999 shares in the last quarter. CWA Asset Management Group LLC acquired a new position in Relx in the third quarter valued at about $548,000. Creative Planning raised its position in shares of Relx by 16.4% during the second quarter. Creative Planning now owns 128,930 shares of the technology company’s stock worth $5,915,000 after purchasing an additional 18,199 shares during the period. International Assets Investment Management LLC bought a new position in shares of Relx during the 3rd quarter valued at about $1,268,000. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Relx by 13.3% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 120,300 shares of the technology company’s stock valued at $5,709,000 after purchasing an additional 14,088 shares during the period. Institutional investors own 15.02% of the company’s stock.

Relx Trading Up 0.6 %

NYSE:RELX opened at $48.18 on Tuesday. Relx Plc has a twelve month low of $40.25 and a twelve month high of $48.91. The business has a 50 day moving average price of $46.44 and a two-hundred day moving average price of $46.59. The company has a quick ratio of 0.42, a current ratio of 0.48 and a debt-to-equity ratio of 1.63.

Analyst Upgrades and Downgrades

RELX has been the topic of a number of research reports. Redburn Atlantic assumed coverage on shares of Relx in a research note on Wednesday, January 8th. They issued a “buy” rating on the stock. StockNews.com began coverage on shares of Relx in a research report on Wednesday, October 30th. They issued a “hold” rating on the stock.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.